Retail Trade Welcia Holdings Co., Ltd. Business Summary
Welcia Holdings Co., Ltd. engages in the management of its subsidiaries and group companies which are in the pharmaceutical business. Its core business deals with the operation of drug store chains which offer prescription drugs and pharmaceuticals, sanitation and nursing care items, health food products, baby supplies, cosmetics, and household sundries. The company was founded on September 1, 2008 and is headquartered in Tokyo, Japan.
Financial Highlights
Feb 2022
JPY USD Revenue 1,025.94B 9,201.33M Gross Profit 302,259M 2,710.84M Operating income 43,020M 385.83M Income before tax 42,410M 380.35M Net income 26,452M 237.23M EBITDA 61,981M 555.88M Diluted EPS 126.98 1.13 Dividends Per Share 30 0.26 Total Assets 463,048M 4,020.38M Total liabilities 255,158M 2,215.39M Total equity 201,785M 1,751.98M Operating cash flow 16,228M 145.54M Currency in JPY Currency in USD
Historical Data Feb 2018 Feb 2019 Feb 2020 Feb 2021 Feb 2022 Revenue
695,268M
779,148M
868,280M
949,652M
1,025.94B
Gross Profit
196,958M
222,431M
252,061M
279,361M
302,259M
Operating income
28,827M
29,046M
37,803M
42,975M
43,020M
Income before tax
26,777M
28,511M
35,936M
41,311M
42,410M
Net income
17,165M
17,423M
22,802M
27,999M
26,452M
EBITDA
42,093M
43,542M
53,466M
59,950M
61,981M
Diluted EPS
82.38
83.53
109.12
134.09
126.98
Dividends Per Share
18.50
21
25
28.50
30
Total Assets
292,238M
327,426M
390,006M
435,685M
463,048M
Total liabilities
161,751M
183,474M
227,584M
255,329M
255,158M
Total equity
129,732M
143,287M
161,925M
179,721M
201,785M
Operating cash flow
35,902M
34,872M
70,156M
46,396M
16,228M
Feb 2018 Feb 2019 Feb 2020 Feb 2021 Feb 2022 Revenue
6,240.85M
7,052.42M
7,965.15M
8,962.27M
9,201.33M
Gross Profit
1,767.93M
2,013.32M
2,312.27M
2,636.45M
2,710.84M
Operating income
258.75M
262.90M
346.78M
405.57M
385.83M
Income before tax
240.35M
258.06M
329.65M
389.86M
380.35M
Net income
154.07M
157.70M
209.17M
264.23M
237.23M
EBITDA
377.83M
394.11M
490.46M
565.77M
555.88M
Diluted EPS
0.73
0.75
1.00
1.26
1.13
Dividends Per Share
0.16
0.19
0.22
0.26
0.26
Total Assets
2,738.74M
2,941.30M
3,615.68M
4,089.40M
4,020.38M
Total liabilities
1,515.87M
1,648.16M
2,109.89M
2,396.55M
2,215.39M
Total equity
1,215.80M
1,287.16M
1,501.18M
1,686.88M
1,751.98M
Operating cash flow
322.26M
315.64M
643.57M
437.85M
145.54M
Valuation Measures
Feb 2022
PER 24.13 ROA 5.88% ROE 13.86% Operating margin 4.19% Profit margin 2.57%
Key executives
President, COO & Representative Director:
Tadahisa Matsumoto
Chief Financial Officer & Senior Managing Director:
Norimasa Sato
Director & Executive Officer:
Takashi Abe
MD, Head-Public Relations, Legal, Operations & IR:
Juichi Nakamura
Auditor:
Toshio Miyamoto Shareholders
AEON Co., Ltd. (50.5%)
Nomura Asset Management Co., Ltd. (1.8%)
Welcia Holdings Employee Stockownership Plan (1.6%)
TSURUHA Holdings, Inc. (1.5%)
The Vanguard Group, Inc. (1.2%)
BlackRock Fund Advisors (1.1%)
T. Rowe Price Associates, Inc. (Investment Management) (0.9%)
Nikko Asset Management Co., Ltd. (0.8%)
Daiwa Asset Management Co. Ltd. (0.8%)
Ishida KK /Kanagawa/ (0.7%)
Contact Details Website: http://www.welcia.co.jp Address:
2-2-15 Sotokanda,
Chiyoda-Ku,
Tokyo,
101-0021,
Japan
Phone:
+81.3.5207.5878
Related Companies
Summit KK
Neo Pharma, Inc.
Kusuri No Marue KK
Masaya KK
IPPONDO Co., Ltd.
Welcia Holdings Board Incentive Plan
Welcia Holdings Employee Incentive Plan 2
Welcia Holdings Employee Incentive Plan 1
Lianhua Meiriling Commercial (Shanghai) Co., Ltd.
Nagata Yakkyoku KK
Kanamitsu Yakuhin KK
Yodoya KK
Pupule Himawari KK
Marudai Sakurai Pharmacy Ltd.
Takiya Co., Ltd.
Welcia Holdings Employee Stockownership Plan
Shimizu Drug KK
Welcia Yakkyoku Co., Ltd.
Competitors
KUSURI NO AOKI HOLDINGS CO.,LTD.
Sundrug Co., Ltd.
TSURUHA Holdings, Inc.
SATUDORA HOLDINGS CO., LTD.
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Last Updated on 16 Aug, 2022
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close